{"id":"various","rwe":[],"tags":[],"safety":{"safetySignals":[{"date":"","signal":"DRUG INEFFECTIVE","source":"FDA FAERS","actionTaken":"Reported 19 times"},{"date":"","signal":"DIZZINESS","source":"FDA FAERS","actionTaken":"Reported 16 times"},{"date":"","signal":"FATIGUE","source":"FDA FAERS","actionTaken":"Reported 16 times"},{"date":"","signal":"DYSPNOEA","source":"FDA FAERS","actionTaken":"Reported 14 times"},{"date":"","signal":"PAIN","source":"FDA FAERS","actionTaken":"Reported 14 times"},{"date":"","signal":"DEPRESSION","source":"FDA FAERS","actionTaken":"Reported 13 times"},{"date":"","signal":"DIARRHOEA","source":"FDA FAERS","actionTaken":"Reported 13 times"},{"date":"","signal":"NAUSEA","source":"FDA FAERS","actionTaken":"Reported 13 times"},{"date":"","signal":"PAIN IN EXTREMITY","source":"FDA FAERS","actionTaken":"Reported 12 times"},{"date":"","signal":"ANXIETY","source":"FDA FAERS","actionTaken":"Reported 11 times"}],"drugInteractions":[{"drug":"Aspirin","action":"Avoid","effect":"Increased risk of bleeding"},{"drug":"Warfarin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Ibuprofen","action":"Avoid","effect":"Increased risk of bleeding"},{"drug":"Clopidogrel","action":"Avoid","effect":"Increased risk of bleeding"},{"drug":"Pain relievers","action":"Avoid","effect":"Increased risk of bleeding"},{"drug":"Antacids","action":"Monitor","effect":"Decreased absorption of various medications"},{"drug":"Cholestyramine","action":"Monitor","effect":"Decreased absorption of various medications"},{"drug":"Colestipol","action":"Monitor","effect":"Decreased absorption of various medications"},{"drug":"Sucralfate","action":"Monitor","effect":"Decreased absorption of various medications"},{"drug":"Antacids","action":"Monitor","effect":"Interference with the absorption of tetracyclines"},{"drug":"Quinolones","action":"Monitor","effect":"Interference with the absorption of tetracyclines"},{"drug":"Iron supplements","action":"Monitor","effect":"Interference with the absorption of tetracyclines"},{"drug":"Calcium supplements","action":"Monitor","effect":"Interference with the absorption of tetracyclines"},{"drug":"Magnesium supplements","action":"Monitor","effect":"Interference with the absorption of tetracyclines"},{"drug":"Aluminum hydroxide","action":"Monitor","effect":"Interference with the absorption of tetracyclines"},{"drug":"Cimetidine","action":"Monitor","effect":"Increased levels of various medications"},{"drug":"Erythromycin","action":"Monitor","effect":"Increased levels of various medications"},{"drug":"Ketoconazole","action":"Monitor","effect":"Increased levels of various medications"},{"drug":"Itraconazole","action":"Monitor","effect":"Increased levels of various medications"},{"drug":"Rifampin","action":"Monitor","effect":"Decreased levels of various medications"},{"drug":"Carbamazepine","action":"Monitor","effect":"Decreased levels of various medications"},{"drug":"Phenytoin","action":"Monitor","effect":"Decreased levels of various medications"},{"drug":"Barbiturates","action":"Monitor","effect":"Decreased levels of various medications"},{"drug":"Ethosuximide","action":"Monitor","effect":"Decreased levels of various medications"},{"drug":"Felbamate","action":"Monitor","effect":"Decreased levels of various medications"},{"drug":"Oxcarbazepine","action":"Monitor","effect":"Decreased levels of various medications"},{"drug":"Primidone","action":"Monitor","effect":"Decreased levels of various medications"},{"drug":"Topiramate","action":"Monitor","effect":"Decreased levels of various medications"},{"drug":"Valproate","action":"Monitor","effect":"Decreased levels of various medications"},{"drug":"Zonisamide","action":"Monitor","effect":"Decreased levels of various medications"},{"drug":"Cyclosporine","action":"Monitor","effect":"Increased levels of cyclosporine"},{"drug":"Tacrolimus","action":"Monitor","effect":"Increased levels of tacrolimus"},{"drug":"Sirolimus","action":"Monitor","effect":"Increased levels of sirolimus"},{"drug":"Erythromycin","action":"Monitor","effect":"Increased levels of erythromycin"},{"drug":"Clarithromycin","action":"Monitor","effect":"Increased levels of clarithromycin"},{"drug":"Azithromycin","action":"Monitor","effect":"Increased levels of azithromycin"},{"drug":"Sulfonamides","action":"Monitor","effect":"Increased risk of methemoglobinemia"},{"drug":"Trimethoprim","action":"Monitor","effect":"Increased risk of methemoglobinemia"},{"drug":"Methotrexate","action":"Monitor","effect":"Increased risk of methotrexate toxicity"},{"drug":"Folic acid","action":"Monitor","effect":"Decreased levels of methotrexate"},{"drug":"Levodopa","action":"Monitor","effect":"Decreased levels of levodopa"},{"drug":"Carbidopa","action":"Monitor","effect":"Decreased levels of levodopa"},{"drug":"Isoniazid","action":"Monitor","effect":"Increased risk of peripheral neuropathy"},{"drug":"Pyridoxine","action":"Monitor","effect":"Decreased risk of peripheral neuropathy"},{"drug":"Phenytoin","action":"Monitor","effect":"Increased risk of Stevens-Johnson syndrome"},{"drug":"Sulfonamides","action":"Monitor","effect":"Increased risk of Stevens-Johnson syndrome"},{"drug":"Trimethoprim","action":"Monitor","effect":"Increased risk of Stevens-Johnson syndrome"},{"drug":"Cyclosporine","action":"Monitor","effect":"Increased risk of nephrotoxicity"},{"drug":"Tacrolimus","action":"Monitor","effect":"Increased risk of nephrotoxicity"},{"drug":"Sirolimus","action":"Monitor","effect":"Increased risk of nephrotoxicity"},{"drug":"Cyclosporine","action":"Monitor","effect":"Increased risk of hypertension"},{"drug":"Tacrolimus","action":"Monitor","effect":"Increased risk of hypertension"},{"drug":"Sirolimus","action":"Monitor","effect":"Increased risk of hypertension"},{"drug":"Cyclosporine","action":"Monitor","effect":"Increased risk of hyperkalemia"},{"drug":"Tacrolimus","action":"Monitor","effect":"Increased risk of hyperkalemia"},{"drug":"Sirolimus","action":"Monitor","effect":"Increased risk of hyperkalemia"},{"drug":"Cyclosporine","action":"Monitor","effect":"Increased risk of hyperuricemia"},{"drug":"Tacrolimus","action":"Monitor","effect":"Increased risk of hyperuricemia"},{"drug":"Sirolimus","action":"Monitor","effect":"Increased risk of hyperuricemia"},{"drug":"Cyclosporine","action":"Monitor","effect":"Increased risk of gingival hyperplasia"},{"drug":"Tacrolimus","action":"Monitor","effect":"Increased risk of gingival hyperplasia"},{"drug":"Sirolimus","action":"Monitor","effect":"Increased risk of gingival hyperplasia"},{"drug":"Cyclosporine","action":"Monitor","effect":"Increased risk of hirsutism"},{"drug":"Tacrolimus","action":"Monitor","effect":"Increased risk of hirsutism"},{"drug":"Sirolimus","action":"Monitor","effect":"Increased risk of hirsutism"},{"drug":"Cyclosporine","action":"Monitor","effect":"Increased risk of tremors"},{"drug":"Tacrolimus","action":"Monitor","effect":"Increased risk of tremors"},{"drug":"Sirolimus","action":"Monitor","effect":"Increased risk of tremors"},{"drug":"Cyclosporine","action":"Monitor","effect":"Increased risk of seizures"},{"drug":"Tacrolimus","action":"Monitor","effect":"Increased risk of seizures"},{"drug":"Sirolimus","action":"Monitor","effect":"Increased risk of seizures"},{"drug":"Cyclosporine","action":"Monitor","effect":"Increased risk of myopathy"},{"drug":"Tacrolimus","action":"Monitor","effect":"Increased risk of myopathy"},{"drug":"Sirolimus","action":"Monitor","effect":"Increased risk of myopathy"},{"drug":"Cyclosporine","action":"Monitor","effect":"Increased risk of alopecia"},{"drug":"Tacrolimus","action":"Monitor","effect":"Increased risk of alopecia"},{"drug":"Sirolimus","action":"Monitor","effect":"Increased risk of alopecia"},{"drug":"Cyclosporine","action":"Monitor","effect":"Increased risk of gynecomastia"},{"drug":"Tacrolimus","action":"Monitor","effect":"Increased risk of gynecomastia"},{"drug":"Sirolimus","action":"Monitor","effect":"Increased risk of gynecomastia"},{"drug":"Cyclosporine","action":"Monitor","effect":"Increased risk of hyperlipidemia"},{"drug":"Tacrolimus","action":"Monitor","effect":"Increased risk of hyperlipidemia"},{"drug":"Sirolimus","action":"Monitor","effect":"Increased risk of hyperlipidemia"},{"drug":"Cyclosporine","action":"Monitor","effect":"Increased risk of hypertension"},{"drug":"Tacrolimus","action":"Monitor","effect":"Increased risk of hypertension"},{"drug":"Sirolimus","action":"Monitor","effect":"Increased risk of hypertension"},{"drug":"Cyclosporine","action":"Monitor","effect":"Increased risk of hyperkalemia"},{"drug":"Tacrolimus","action":"Monitor","effect":"Increased risk of hyperkalemia"},{"drug":"Sirolimus","action":"Monitor","effect":"Increased risk of hyperkalemia"},{"drug":"Cyclosporine","action":"Monitor","effect":"Increased risk of hyperuricemia"},{"drug":"Tacrolimus","action":"Monitor","effect":"Increased risk of hyperuricemia"},{"drug":"Sirolimus","action":"Monitor","effect":"Increased risk of hyperuricemia"},{"drug":"Cyclosporine","action":"Monitor","effect":"Increased risk of gingival hyperplasia"},{"drug":"Tacrolimus","action":"Monitor","effect":"Increased risk of gingival hyperplasia"},{"drug":"Sirolimus","action":"Monitor","effect":"Increased risk of gingival hyperplasia"},{"drug":"Cyclosporine","action":"Monitor","effect":"Increased risk of hirsutism"},{"drug":"Tacrolimus","action":"Monitor","effect":"Increased risk of hirsutism"},{"drug":"Sirolimus","action":"Monitor","effect":"Increased risk of hirsutism"},{"drug":"Cyclosporine","action":"Monitor","effect":"Increased risk of tremors"},{"drug":"Tacrolimus","action":"Monitor","effect":"Increased risk of tremors"},{"drug":"Sirolimus","action":"Monitor","effect":"Increased risk of tremors"},{"drug":"Cyclosporine","action":"Monitor","effect":"Increased risk of seizures"},{"drug":"Tacrolimus","action":"Monitor","effect":"Increased risk of seizures"},{"drug":"Sirolimus","action":"Monitor","effect":"Increased risk of seizures"},{"drug":"Cyclosporine","action":"Monitor","effect":"Increased risk of myopathy"},{"drug":"Tacrolimus","action":"Monitor","effect":"Increased risk of myopathy"},{"drug":"Sirolimus","action":"Monitor","effect":"Increased risk of myopathy"},{"drug":"Cyclosporine","action":"Monitor","effect":"Increased risk of alopecia"},{"drug":"Tacrolimus","action":"Monitor","effect":"Increased risk of alopecia"},{"drug":"Sirolimus","action":"Monitor","effect":"Increased risk of alopecia"}],"commonSideEffects":[],"contraindications":["renal impairment","gastrointestinal disorders","heart block","antibiotics","blood thinners","medications for diabetes","medications for hypertension"],"specialPopulations":{"Pregnancy":"Women with CKD should be advised that there is an increased risk of complications in pregnancy, including. Women with CKD stages 4 and 5 contemplating pregnancy should be offered pre-dialysis education. Women can breastfeed while taking prednisolone, hydroxychloroquine, azathioprine, ciclosporin, tacrolimus, enalapril, captopril, amlodipine, nifedipine, labetalol, atenolol, and low molecular weight heparin.","Geriatric use":"No information available","Paediatric use":"No information available","Renal impairment":"Women with CKD should have formal quantification of proteinuria in pregnancy. Concentrations of calcineurin inhibitors (tacrolimus, ciclosporin) should be checked throughout pregnancy and. Women with CKD stages 4 and 5 contemplating pregnancy should be offered pre-dialysis education.","Hepatic impairment":"No information available"}},"trials":[],"aliases":[],"company":"Pfizer","patents":[],"pricing":[],"_recalls":[{"date":"20150128","reason":"Lack of sterility assurance.","classification":"Class II"},{"date":"20150128","reason":"Lack of sterility assurance.","classification":"Class II"},{"date":"20210818","reason":"Non-Sterility","classification":"Class I"},{"date":"20150128","reason":"Lack of sterility assurance.","classification":"Class II"},{"date":"20150128","reason":"Lack of sterility assurance.","classification":"Class II"}],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=various","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-19T23:38:49.501801+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-19T23:38:55.302139+00:00"},"regulatory.eu":{"url":"","method":"api_direct","source":"European Medicines Agency","rawText":"","confidence":1,"sourceType":"ema_api","retrievedAt":"2026-04-19T23:38:49.571166+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=various","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-19T23:38:55.592689+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2106384/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-19T23:38:56.493795+00:00"}},"offLabel":[],"timeline":[],"aiSummary":"Pfizer's drug is a marketed treatment for various bacterial infections. It has a revenue of $63.6 billion and has been involved in 100 trials. The drug's mechanism is not specified on Wikipedia. It is indicated for acute bacterial exacerbation of chronic bronchitis, acute bacterial sinusitis, acute pyelonephritis, community-acquired bacterial pneumonia, and complicated urinary tract infections. The drug's clinical differentiation and commercial significance are not specified. There are no pipeline developments mentioned.","brandName":"Various","ecosystem":[],"isGeneric":true,"mechanism":{"target":"Not specified","novelty":"Best-in-class","modality":"Small molecule","drugClass":"Antibiotic","explanation":"","oneSentence":"","technicalDetail":"The exact mechanism of action for this drug is not publicly available. It is likely to involve the inhibition of bacterial growth or the enhancement of the immune response."},"_companyIR":{"url":"https://www.pfizer.com/investors","revenueRefs":[],"pipelineRefs":[]},"commercial":{"yoyGrowth":"7%","annualCostUS":"80,000","genericStatus":"Generic — off-patent","currentRevenue":"","peakSalesEstimate":""},"references":[{"id":1,"url":"https://clinicaltrials.gov/search?intr=various","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=various","fields":["publications"],"source":"PubMed/NCBI"},{"id":3,"url":"https://www.ebi.ac.uk/chembl/","fields":["molecular"],"source":"ChEMBL (EMBL-EBI)"},{"id":4,"url":"https://open.fda.gov/apis/drug/event/","fields":["safetySignals"],"source":"FDA FAERS"},{"id":5,"url":"https://www.ema.europa.eu/","fields":["regulatoryStatus"],"source":"European Medicines Agency (EMA)"},{"id":6,"url":"https://list.essentialmeds.org/","fields":["regulatoryStatus"],"source":"WHO Essential Medicines List"}],"_tgaChecked":true,"_validation":{"fieldsValidated":2,"lastValidatedAt":"2026-04-20T08:28:31.942264+00:00","fieldsConflicting":0,"overallConfidence":0.95},"_whoChecked":true,"biosimilars":[],"competitors":[{"name":"Tirzepatide (Zepbound)","company":"Dual GIP/GLP-1; chronic weight management","advantage":"~16–21% mean loss at 72 wks; outperformed semaglutide 2.4 mg in a head-to-head trial"},{"name":"Rybelsus (oral semaglutide)","company":"GLP-1; T2D (not weight loss)","advantage":"~4.4 kg loss at 26 wks in T2D"},{"name":"Saxenda (liraglutide 3.0 mg)","company":"GLP-1; weight management","advantage":"~5–10% average"},{"name":"Phentermine/topiramate (Qsymia)","company":"Combination; weight management","advantage":"~8–12% mean; up to ~14%"},{"name":"Naltrexone/bupropion (Contrave)","company":"Combination; weight management","advantage":"~5–9% mean"},{"name":"SGLT-2 inhibitors (e.g., empagliflozin)","company":"T2D; CV/renal benefits","advantage":"~2–3 kg average"},{"name":"Mounjaro (Tirzepatide)","company":"Dual GIP/GLP-1; chronic weight management","advantage":"Related reading: Mounjaro vs. Ozempic and Zepbound results overview"},{"name":"CagriSema (cagrilintide + semaglutide)","company":"Not FDA-approved","advantage":"Phase 3 readouts pending"},{"name":"Orglirpliron (oral small-molecule GLP-1)","company":"Once-daily pill in Phase 3","advantage":"Significant A1C and weight reductions"},{"name":"Retatrutide (triple GLP-1/GIP/glucagon agonist)","company":"Not FDA-approved","advantage":"~24% mean loss"}],"genericName":"various","indications":{"approved":[{"name":"Acute bacterial exacerbation of chronic bronchitis","regulator":"FDA"},{"name":"Acute bacterial sinusitis","regulator":"FDA"},{"name":"Acute pyelonephritis","regulator":"FDA"},{"name":"Community-acquired bacterial pneumonia","regulator":"FDA"},{"name":"Complicated urinary tract infections","regulator":"FDA"},{"name":"Uncomplicated urinary tract infections","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"},{"name":"Platonicus","regulator":"FDA"}],"offLabel":[],"pipeline":[]},"_drugWebsite":{"url":"https://www.various.com","content":"  \n  \n \n   Menu    Close    \n \n  \n\n\nHome // \nJobs // \nWhy Work Here // \nAbout Us     \n \n  \n   \n \nVarious Inc   \n   \n\n\nHome // \nJobs // \nWhy Work Here // \nAbout Us         \n \n \n  \n \n \n \n \n\n \n\n \nis a worldwide leader in social networking, online dating and entertainment. Our wide range of products afford our employees the unique opportunity to constantly work on new and exciting projects while enjoying perks such as catered breakfasts/lunches and gym membership reimbursements. All that, along with our casual environment of a relaxed dress code make it a great (and dare we say fun?) place to work. So apply now and become one of the many employees who love being a part of the Various team! \n \nApply Now   \n\n \n          \n \n \n \n \n 2022 Various, Inc             "},"_mhraChecked":true,"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT07495839","phase":"NA","title":"The Impact of Equine-Assisted Therapy on Mental Health and Addictive Behaviors in Patients Receiving Addiction Treatment","status":"NOT_YET_RECRUITING","sponsor":"Hopital La Musse","startDate":"2026-04-01","conditions":"Equine-assisted Therapy, Addiction, Recidivism","enrollment":22},{"nctId":"NCT07293676","phase":"NA","title":"IASTM and Vibration Effects on Pain, Functionality, and Kinesiophobia in Lumbar Disc Herniation","status":"RECRUITING","sponsor":"Istanbul Medipol University Hospital","startDate":"2026-01-05","conditions":"Vibration, Lumbar Disc Herniation, Soft Tissue Mobilization","enrollment":45},{"nctId":"NCT07305961","phase":"","title":"National Study on the Epidemiology and Effectiveness of Therapies in the Treatment of Scabies","status":"COMPLETED","sponsor":"Societa Italiana di Dermatologia Medica, Chirurgica, Estetica e di Malattie Sessualmente Trasmesse","startDate":"2025-01-07","conditions":"Scabies","enrollment":1332},{"nctId":"NCT06545214","phase":"NA","title":"Caracterization of the Combined Alterations in Respiration and aROUSal in Patients With Drug-resistant EpiLepsy","status":"RECRUITING","sponsor":"Hospices Civils de Lyon","startDate":"2024-11-04","conditions":"Epilepsy","enrollment":60},{"nctId":"NCT07494357","phase":"NA","title":"Effects of Dual Task-Oriented Circuit Training on Walking Recovery in Sub-acute Stroke","status":"NOT_YET_RECRUITING","sponsor":"Universitas Padjadjaran","startDate":"2026-04-01","conditions":"Stroke, Cerebrovascular","enrollment":36},{"nctId":"NCT07413458","phase":"NA","title":"Virtual Reality (VR) NATURE - Alcohol Use Disorder (AUD)","status":"RECRUITING","sponsor":"University of Michigan","startDate":"2026-02-16","conditions":"Alcohol Use Disorder","enrollment":50},{"nctId":"NCT07495696","phase":"","title":"Possibilities of Recording Changes in Various Health Parameters by Measuring Bioimpedance With the mBCA 555 During the Use of Products From the L112 Product Range","status":"COMPLETED","sponsor":"Certmedica International GmbH","startDate":"2025-04-15","conditions":"Overweight","enrollment":41},{"nctId":"NCT07495891","phase":"NA","title":"Sustainability of the Effects of an Adapted Physical Activity Program on Physical Fitness and Psycho-behavioral Factors in Patients With Chronic Diseases","status":"NOT_YET_RECRUITING","sponsor":"Hopital La Musse","startDate":"2026-03-30","conditions":"Adapted Physical Activity, Smartwatches, Chronic Disease","enrollment":280},{"nctId":"NCT07494864","phase":"","title":"Effects of Microbiological and Immunological Factors on the Lower Urinary Tract","status":"RECRUITING","sponsor":"University of Zurich","startDate":"2023-06-01","conditions":"Asymptomatic Bacteriuria in Subjects Not Requiring Assisted Bladder Emptying, Asymptomatic Bacteriuria in Subjects Relying on Some Type of Catheter, Recurrent Non-catheter Associated UTIs","enrollment":800},{"nctId":"NCT07027826","phase":"NA","title":"The Esophageal String Test as a Diagnostic Screening Tool for Eosinophilic Esophagitis Among Africans With Dysphagia in Mali and the United States","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2026-04-01","conditions":"Dysphagia, Eosinophilic Esophagitis","enrollment":70},{"nctId":"NCT05281484","phase":"","title":"Two Intermediate Expanded Access Protocols (EAP) CNMAu8.EAP01 and CNMAu8.EAP02 for ALS","status":"AVAILABLE","sponsor":"Clene Nanomedicine","startDate":"","conditions":"Amyotrophic Lateral Sclerosis","enrollment":""},{"nctId":"NCT07394738","phase":"NA","title":"Using Different Biomaterials to Preserve Bone After Tooth Extraction","status":"ACTIVE_NOT_RECRUITING","sponsor":"Inonu University","startDate":"2025-04-09","conditions":"Alveolar Ridge Preservation, Bone Regeneration, Tooth Extraction","enrollment":40},{"nctId":"NCT04856462","phase":"NA","title":"The Alzheimer's Companion Engagement (ACE) Project.","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2025-03-06","conditions":"Stress, Psychological, Adaptation, Psychological","enrollment":25},{"nctId":"NCT07105930","phase":"NA","title":"Trial to Assess Non-inferiority of an Orbital Atherectomy Only Versus a Calcium-tailored Debulking Approach","status":"RECRUITING","sponsor":"IHF GmbH - Institut für Herzinfarktforschung","startDate":"2025-10-30","conditions":"Orbital Atherectomy","enrollment":310},{"nctId":"NCT06930170","phase":"NA","title":"Evaluation of Cochlear Implantation in Unilateral or Asymmetric Hearing Loss in Children.","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2026-03-09","conditions":"Unilateral Hearing Loss, Asymmetric Hearing Loss","enrollment":36},{"nctId":"NCT07498725","phase":"PHASE1, PHASE2","title":"A Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of LRK-4189 Alone and in Combination in Patients With Solid Tumors","status":"NOT_YET_RECRUITING","sponsor":"LARKSPUR BIOSCIENCES, INC.","startDate":"2026-05","conditions":"Neoplasms","enrollment":120},{"nctId":"NCT01859299","phase":"","title":"Intestinal Bacteria and Ocular Inflammatory Disease","status":"COMPLETED","sponsor":"National Eye Institute (NEI)","startDate":"2013-08-27","conditions":"Uveitis","enrollment":131},{"nctId":"NCT00018057","phase":"PHASE2","title":"Study of Neuro-Cognitive Correlates of Pediatric Anxiety Disorders","status":"RECRUITING","sponsor":"National Institute of Mental Health (NIMH)","startDate":"2001-10-02","conditions":"Anxiety Disorders, Major Depressive Disorder","enrollment":3500},{"nctId":"NCT06805721","phase":"","title":"This Three-year Observational Study Involves Patients of All Ages Undergoing Endovascular Treatment for Various Cerebral or Spinal Vascular Conditions. It Aims to Assess Pre- and Post-operative Clinical Conditions, Report Complications, and Identify Preoperative Indicators of Treatment Outcomes. Pat","status":"RECRUITING","sponsor":"Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta","startDate":"2023-02-06","conditions":"Aneurysm Cerebral, AVM, DAFV","enrollment":1000},{"nctId":"NCT02535702","phase":"NA","title":"Development Of Neuroimaging Methods To Assess The Neurobiology Of Addiction","status":"RECRUITING","sponsor":"National Institute on Alcohol Abuse and Alcoholism (NIAAA)","startDate":"2016-06-28","conditions":"Normal Physiology","enrollment":192},{"nctId":"NCT05646589","phase":"NA","title":"A Person-centred Care Transition Support for People With Stroke/TIA","status":"COMPLETED","sponsor":"Karolinska Institutet","startDate":"2022-11-21","conditions":"Stroke, Transient Ischemic Attack","enrollment":213},{"nctId":"NCT07284316","phase":"PHASE2, PHASE3","title":"Effect of a Multidomain Intervention Plus Turmeric on the Prevention of Cognitive Decline in People Over 55 Years of Age With Insulin Resistance.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Instituto Mexicano del Seguro Social","startDate":"2025-02-20","conditions":"Cognitive Decline, Subjective Cognitive Impairment, Insulin Resistance","enrollment":100},{"nctId":"NCT05272046","phase":"NA","title":"Monopolar and Bipolar Current RFA Knife in POEM","status":"ACTIVE_NOT_RECRUITING","sponsor":"Baylor College of Medicine","startDate":"2022-02-22","conditions":"Esophageal Motility Disorders","enrollment":105},{"nctId":"NCT07075900","phase":"NA","title":"Dynamic Neuromuscular Stabilization vs Pelvic Floor Muscle Training in Women With Stress Urinary Incontinence","status":"RECRUITING","sponsor":"Izmir Katip Celebi University","startDate":"2025-07-16","conditions":"Stress Urinary Incontinence (SUI), Dynamic Neuromuscular Stabilization, Pelvic Floor Muscle Training","enrollment":51},{"nctId":"NCT07361341","phase":"NA","title":"Culturally Tailored Program for Food-Insecure Adults: SPICE-D","status":"NOT_YET_RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2026-04","conditions":"Type 2 Diabetes Mellitus (T2D)","enrollment":25},{"nctId":"NCT07230132","phase":"PHASE2","title":"Efficacy and Safety of ZT006 in Overweight and Obese Participants","status":"ACTIVE_NOT_RECRUITING","sponsor":"Beijing QL Biopharmaceutical Co.,Ltd","startDate":"2025-12-12","conditions":"Overweight , Obesity","enrollment":184},{"nctId":"NCT07492745","phase":"NA","title":"Effect of Using a Reminder to Encourage Patients to be Active During Their Hospital Stay.","status":"RECRUITING","sponsor":"Groupe Hospitalier du Havre","startDate":"2025-11-19","conditions":"Inpatients, Frail","enrollment":204},{"nctId":"NCT07490509","phase":"PHASE4","title":"Pharmacokinetic Model of Abemaciclib: Correlation With Severe Diarrhea as the Primary Toxicity Endpoint in Patients With Localized Hormone Receptor-positive Breast Cancer","status":"NOT_YET_RECRUITING","sponsor":"Poitiers University Hospital","startDate":"2026-04","conditions":"Abemaciclib, Abemaciclib-related Diarrhea, Breast Cancer","enrollment":235},{"nctId":"NCT07262255","phase":"NA","title":"WATCHMAN FLX Pro European Registry","status":"RECRUITING","sponsor":"Boston Scientific Corporation","startDate":"2025-12-17","conditions":"Non-valvular Atrial Fibrillation (AF), Left Atrial Appendage Closure","enrollment":1000},{"nctId":"NCT06185608","phase":"NA","title":"The Effects of Various Concentrations of Ropivacaine on the Onset and Duration of Ankle Blocks","status":"RECRUITING","sponsor":"Ziekenhuis Oost-Limburg","startDate":"2025-05-22","conditions":"Hallux Valgus, Anesthesia","enrollment":174},{"nctId":"NCT07490067","phase":"PHASE4","title":"Mechanistic Clinical Trial Comparing the Pharmacokinetics/Pharmacodynamics of Metoprolol in Heart Failure With Reduced Ejection Fraction Patients With Low vs. High Polygenic Score","status":"NOT_YET_RECRUITING","sponsor":"University of Michigan","startDate":"2026-04","conditions":"Heart Failure With Reduced Ejection Fraction","enrollment":100},{"nctId":"NCT07362082","phase":"NA","title":"A Clinical Trial of Telehealth Treatment for Opioid Use Disorders","status":"NOT_YET_RECRUITING","sponsor":"Yale University","startDate":"2026-04-15","conditions":"Opioid Use Disorder","enrollment":470},{"nctId":"NCT06820463","phase":"PHASE2","title":"A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer","status":"RECRUITING","sponsor":"AbbVie","startDate":"2025-04-24","conditions":"Metastatic Colorectal Cancer","enrollment":390},{"nctId":"NCT06189924","phase":"","title":"Exhaled Breath Condensate Analysis in Mechanically Ventilated Patients","status":"RECRUITING","sponsor":"The Institute of Molecular and Translational Medicine, Czech Republic","startDate":"2026-03-01","conditions":"Acute Respiratory Failure, Critical Illness","enrollment":200},{"nctId":"NCT07488390","phase":"NA","title":"Escape Room Simulation vs Case-Based Learning for Vital Sign Measurement in Nursing Students","status":"ACTIVE_NOT_RECRUITING","sponsor":"Acibadem University","startDate":"2026-01-01","conditions":"Nursing Education, Vital Signs, Simulation Based Learning","enrollment":45},{"nctId":"NCT07485725","phase":"NA","title":"Center for Research and Education on Aging and Technology Enhancement - CREATE V - Project 3","status":"NOT_YET_RECRUITING","sponsor":"Weill Medical College of Cornell University","startDate":"2026-04-30","conditions":"Mild Cognitive Impairment","enrollment":600},{"nctId":"NCT06248073","phase":"NA","title":"Effectiveness of Online Program and Task-related Training for Parkinson's Disease","status":"RECRUITING","sponsor":"Chang Gung University","startDate":"2024-03-01","conditions":"Parkinson Disease, Occupational Therapy, Telerehabilitation","enrollment":100},{"nctId":"NCT06258538","phase":"NA","title":"Effects of Circuit Training Combining Different Types of Distal Robot-assisted and Task-oriented Therapy on Motor Control, Motor and Daily Functions, and Quality of Life After Stroke","status":"RECRUITING","sponsor":"Chang Gung Memorial Hospital","startDate":"2024-06-01","conditions":"Stroke Patients","enrollment":87},{"nctId":"NCT06694584","phase":"NA","title":"Study: Tea(m)Time - Strengthening the Team Resilience of Hospital Staff Through the Tea(m)Time Intervention","status":"RECRUITING","sponsor":"Catholic University of Applied Sciences Mainz","startDate":"2024-03-04","conditions":"Resilience, Psychological, Personnel, Hospital","enrollment":150},{"nctId":"NCT07478939","phase":"","title":"Study on the Level of Physical Activity in Patients Diagnosed With Breast Cancer in Spain","status":"COMPLETED","sponsor":"Spanish Breast Cancer Research Group","startDate":"2025-01-08","conditions":"Breast Cancer","enrollment":507},{"nctId":"NCT05374174","phase":"","title":"Validation of a Spasticity Measurement Tool","status":"ACTIVE_NOT_RECRUITING","sponsor":"Shirley Ryan AbilityLab","startDate":"2022-04-28","conditions":"Stroke","enrollment":40},{"nctId":"NCT07484919","phase":"NA","title":"Virtual Reality Intervention (VR-GINSO) for Reducing Aggression in Young Offenders","status":"RECRUITING","sponsor":"Universidad Francisco de Vitoria","startDate":"2025-12-15","conditions":"Aggression","enrollment":110},{"nctId":"NCT06389032","phase":"NA","title":"PERSEVERE: Peer Mentor Support and Caregiver Education in Lewy Body Dementia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Rush University Medical Center","startDate":"2024-05-13","conditions":"Lewy Body Dementia, Parkinson Disease Dementia, Dementia With Lewy Bodies","enrollment":622},{"nctId":"NCT05065736","phase":"EARLY_PHASE1","title":"Using a PET Imaging Agent, 18F-Clofarabine (CFA), to Measure Deoxycytidine Kinase Activity in Metastatic Cancer","status":"RECRUITING","sponsor":"Roberto Vargas","startDate":"2023-03-06","conditions":"Metastatic Cancer, Carcinoma, Adenocarcinoma","enrollment":4},{"nctId":"NCT05680519","phase":"NA","title":"Screening and Educating Emergency Department Attendees on Health-risk Behaviours","status":"COMPLETED","sponsor":"Chinese University of Hong Kong","startDate":"2023-02-20","conditions":"Health-risk Behaviours, Non Communicable Diseases","enrollment":150},{"nctId":"NCT04973605","phase":"PHASE1, PHASE2","title":"A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma","status":"RECRUITING","sponsor":"BeOne Medicines","startDate":"2021-09-16","conditions":"Relapsed/Refractory Multiple Myeloma","enrollment":246},{"nctId":"NCT07481812","phase":"NA","title":"Prolapsed Hemorrhoids: Assessment of Various Surgical Modalities","status":"COMPLETED","sponsor":"Theodor Bilharz Research Institute","startDate":"2024-04-05","conditions":"Piles","enrollment":90},{"nctId":"NCT05790395","phase":"NA","title":"Prevention of NCDs Through Screening and Educating Individuals on Health-risk Behaviours in the Community","status":"COMPLETED","sponsor":"Chinese University of Hong Kong","startDate":"2023-07-13","conditions":"Health-risk Behaviours, Non Communicable Diseases","enrollment":330},{"nctId":"NCT06684613","phase":"NA","title":"Integrating PrEP Decision Making Into Counseling in Sexual and Reproductive Health Clinics","status":"RECRUITING","sponsor":"Yale University","startDate":"2026-03-11","conditions":"Sexual Risk Behavior for HIV-infection, Reproductive Health","enrollment":50},{"nctId":"NCT04570163","phase":"","title":"Berlin Registry of Right Heart Interventions","status":"RECRUITING","sponsor":"Charite University, Berlin, Germany","startDate":"2020-06-16","conditions":"Tricuspid Regurgitation, Pulmonary Regurgitation","enrollment":200},{"nctId":"NCT04460313","phase":"NA","title":"Nasopharyngeal Carriage of S. Pneumoniae","status":"RECRUITING","sponsor":"Association Clinique Thérapeutique Infantile du val de Marne","startDate":"2001-09-11","conditions":"Nasopharyngeal Carriage, Children, Only, Antibiotic Resistant Strain","enrollment":25760},{"nctId":"NCT04678167","phase":"NA","title":"Boarding Ring Glasses Versus Placebo Glasses or Not Glasses in the Treatment of Vestibular Neuritis","status":"RECRUITING","sponsor":"University Hospital, Brest","startDate":"2021-03-10","conditions":"Vestibular Neuritis","enrollment":51},{"nctId":"NCT07482371","phase":"NA","title":"Comparative Effects of Scooping Mobilization and Dynamic Cupping Therapy on Elbow Stiffness","status":"RECRUITING","sponsor":"Riphah International University","startDate":"2025-10-22","conditions":"Children, Adults","enrollment":28},{"nctId":"NCT05511597","phase":"NA","title":"Split-belt Treadmill Training for Freezing of Gait in Parkinson's Disease","status":"COMPLETED","sponsor":"KU Leuven","startDate":"2022-12-16","conditions":"Parkinson Disease, Freezing of Gait, Split-belt Treadmill","enrollment":26},{"nctId":"NCT02737878","phase":"NA","title":"Reshaping the Path of Mild Cognitive Impairment by Refining Exercise Prescription","status":"COMPLETED","sponsor":"University of British Columbia","startDate":"2017-11-13","conditions":"Mild Cognitive Impairment","enrollment":226},{"nctId":"NCT06340503","phase":"NA","title":"Evaluating a Physical Activity Index for Assessment and Counseling for Breast and Colon Cancer Survivors","status":"ACTIVE_NOT_RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2024-11-06","conditions":"Breast Cancer, Colon Cancer","enrollment":20},{"nctId":"NCT07345117","phase":"NA","title":"Cost-effectiveness and Implementation of a Transdiagnostic Internet-based Intervention for Emotional Disorders in Community Care.","status":"NOT_YET_RECRUITING","sponsor":"Universitat Jaume I","startDate":"2026-04-01","conditions":"Emotional Disorders, Depression Anxiety Disorder, Depression Disorders","enrollment":200},{"nctId":"NCT05854654","phase":"NA","title":"Air Leak Detection and Treatment","status":"RECRUITING","sponsor":"Centre hospitalier de l'Université de Montréal (CHUM)","startDate":"2023-05-02","conditions":"Air Leak From Lung","enrollment":200},{"nctId":"NCT06644391","phase":"","title":"Enhancing Diagnostic Accuracy in Fracture Identification on Musculoskeletal Radiographs Using Deep Learning","status":"COMPLETED","sponsor":"Carebot s.r.o.","startDate":"2023-03-20","conditions":"Fractures, Musculoskeletal","enrollment":600},{"nctId":"NCT07025291","phase":"NA","title":"Assessment of Salivary Biomarker Levels in Individuals With Various Periodontal Diseases","status":"COMPLETED","sponsor":"Izmir Katip Celebi University","startDate":"2025-01-10","conditions":"Periodontal Diseases","enrollment":60},{"nctId":"NCT05964010","phase":"NA","title":"Primary Connections for Youth and Families","status":"RECRUITING","sponsor":"The National Center on Addiction and Substance Abuse at Columbia University","startDate":"2024-03-01","conditions":"Substance Use","enrollment":2300},{"nctId":"NCT06196034","phase":"","title":"Genetic Association With Various Severities, Phenotypes and Endotypes of Asthma.","status":"RECRUITING","sponsor":"Chinese University of Hong Kong","startDate":"2024-03-01","conditions":"Asthma","enrollment":2000},{"nctId":"NCT06207123","phase":"PHASE1, PHASE2","title":"A Study to Investigate LP-118, Ponatinib, Vincristine and Dexamethasone in Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL)","status":"RECRUITING","sponsor":"University of Chicago","startDate":"2024-09-13","conditions":"Acute Leukemia, Lymphoblastic Leukemia, Lymphoblastic Lymphoma","enrollment":15},{"nctId":"NCT04927429","phase":"","title":"Technical Development of Cardiovascular Magnetic Resonance Imaging","status":"RECRUITING","sponsor":"National Heart, Lung, and Blood Institute (NHLBI)","startDate":"2024-04-08","conditions":"Cardiovascular Disease","enrollment":3400},{"nctId":"NCT01019343","phase":"NA","title":"Physiological Investigations of Movement Disorders","status":"COMPLETED","sponsor":"National Institute of Neurological Disorders and Stroke (NINDS)","startDate":"2009-12-08","conditions":"Parkinson's Disease, Tourette's Syndrome, Tic Disorders","enrollment":1273},{"nctId":"NCT02669394","phase":"NA","title":"Reshaping the Path of Vascular Cognitive Impairment (VCI)","status":"COMPLETED","sponsor":"University of British Columbia","startDate":"2016-05-17","conditions":"Transient Ischemic Attack, Vascular Cognitive Impairment, Subcortical Vascular Dementia","enrollment":91},{"nctId":"NCT07227558","phase":"NA","title":"Improving Information Sharing Between Family Caregivers and Home Care Aides","status":"RECRUITING","sponsor":"Johns Hopkins Bloomberg School of Public Health","startDate":"2026-04-15","conditions":"Shared Care","enrollment":100},{"nctId":"NCT05167786","phase":"NA","title":"Locomotor Function Following Transcutaneous Electrical Spinal Cord Stimulation in Individuals With Hemiplegic Stroke","status":"RECRUITING","sponsor":"Shirley Ryan AbilityLab","startDate":"2022-03-01","conditions":"Stroke","enrollment":115},{"nctId":"NCT07399925","phase":"NA","title":"Assessment of the Impact of Oral Health Training for Caregivers on the Oral Health-related Quality of Life of Residents in Nursing Homes","status":"RECRUITING","sponsor":"Nantes University Hospital","startDate":"2026-03-06","conditions":"Oral Health Training","enrollment":99},{"nctId":"NCT07310030","phase":"NA","title":"Neuro-Athletic Training Effects in Young Adults","status":"COMPLETED","sponsor":"Istinye University","startDate":"2026-01-01","conditions":"Health Young Individuals, Physical Fitness","enrollment":22},{"nctId":"NCT02836080","phase":"NA","title":"Integrated Collaborative Care Teams for Youth With Mental Health and/or Addiction Challenges (YouthCan IMPACT)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Centre for Addiction and Mental Health","startDate":"2016-09","conditions":"Mental Disorders, Addiction","enrollment":247},{"nctId":"NCT06604754","phase":"NA","title":"Effects of VR Training on Balance and Fall Risk of Patients With COPD","status":"COMPLETED","sponsor":"Riphah International University","startDate":"2025-06-12","conditions":"COPD (Chronic Obstructive Pulmonary Disease)","enrollment":50},{"nctId":"NCT06801132","phase":"NA","title":"The Effectiveness of an Online Self-Delivered Death Anxiety Intervention","status":"COMPLETED","sponsor":"Peking University","startDate":"2025-02-14","conditions":"Death Anxiety","enrollment":47},{"nctId":"NCT04959526","phase":"NA","title":"Shear-wave Elastography Compared to Respiratory Function Testing","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2021-07-28","conditions":"Respiratory Function Loss, Respiratory Complication","enrollment":24},{"nctId":"NCT06154694","phase":"","title":"Glenohumeral Joint Contract Patterns in Osteoarthritic Glenoids","status":"RECRUITING","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2021-11-03","conditions":"Osteoarthritis of Shoulder","enrollment":52},{"nctId":"NCT06693661","phase":"NA","title":"Collaborative Learning to Achieve Refined Interventions for Emory: Kidney Disease","status":"RECRUITING","sponsor":"Emory University","startDate":"2026-03-10","conditions":"Kidney Diseases","enrollment":600},{"nctId":"NCT04794595","phase":"","title":"Clinical Features and Outcomes of CBP Versus Non-CBP in Septic Children","status":"RECRUITING","sponsor":"Children's Hospital of Fudan University","startDate":"2020-12-01","conditions":"Sepsis, Children, Only","enrollment":90},{"nctId":"NCT07472374","phase":"PHASE3","title":"Functional Restoration for Chronic Low Back Pain: Medico-economic Impact","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2026-03-10","conditions":"Nonspecific Chronic Low Back Pain With Work Disability","enrollment":242},{"nctId":"NCT04961580","phase":"","title":"PK/PD of Ceftazidime Avitbatan Sodium in Children With Severe Infection","status":"RECRUITING","sponsor":"Children's Hospital of Fudan University","startDate":"2022-10-01","conditions":"Sepsis, Antibiotic Reaction","enrollment":30},{"nctId":"NCT07475091","phase":"NA","title":"Standardizing Swallow Pressure Measurements","status":"NOT_YET_RECRUITING","sponsor":"University of Wisconsin, Madison","startDate":"2026-05","conditions":"Dysphagia","enrollment":25},{"nctId":"NCT03485209","phase":"PHASE2","title":"Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors","status":"ACTIVE_NOT_RECRUITING","sponsor":"Seagen, a wholly owned subsidiary of Pfizer","startDate":"2018-06-25","conditions":"Colorectal Neoplasms, Carcinoma, Non-Small-Cell Lung, Exocrine Pancreatic Cancer","enrollment":352},{"nctId":"NCT07108634","phase":"","title":"Cost-effectiveness Analyses for the Prevention of Acute Kidney Injury in Patients Undergoing Cardiac Surgery in the UK","status":"WITHDRAWN","sponsor":"The Royal Wolverhampton Hospitals NHS Trust","startDate":"2026-03","conditions":"Acute Kidney Injury","enrollment":0},{"nctId":"NCT07342218","phase":"NA","title":"Correctional Service of Canada Pilot Trial of Digital Substance Use Disorder Interventions (PROCESS)","status":"RECRUITING","sponsor":"St. Joseph's Healthcare Hamilton","startDate":"2026-02-25","conditions":"Substance Use Disorder (SUD)","enrollment":20},{"nctId":"NCT06892379","phase":"PHASE1","title":"A Study of HS-20110 in Participants With Advanced Solid Tumors","status":"RECRUITING","sponsor":"Hansoh BioMedical R&D Company","startDate":"2025-02-26","conditions":"Solid Tumors","enrollment":475},{"nctId":"NCT07460492","phase":"NA","title":"Plyometric Strength-Endurance Exercise in Breast Cancer","status":"NOT_YET_RECRUITING","sponsor":"University of Vigo","startDate":"2026-04-20","conditions":"Neoplams, Patients, Cancer Survivors","enrollment":51},{"nctId":"NCT06315322","phase":"PHASE3","title":"A Study to Test the Long-term Safety and Tolerability of Brivaracetam in Study Participants With Childhood Absence Epilepsy or Juvenile Absence Epilepsy","status":"RECRUITING","sponsor":"UCB Biopharma SRL","startDate":"2024-07-10","conditions":"Childhood Absence Epilepsy, Juvenile Absence Epilepsy","enrollment":120},{"nctId":"NCT07470372","phase":"NA","title":"Experimental Trial of an Employment-Based Housing Program for Adults at Risk of Homelessness: Housing Integrated With Residential Employment","status":"NOT_YET_RECRUITING","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2026-03-15","conditions":"Emergency Department Visits, Housing Stability, Employment","enrollment":750},{"nctId":"NCT05639556","phase":"","title":"Strength and Muscle Related Outcomes for Nutrition and Lung Function in CF","status":"ACTIVE_NOT_RECRUITING","sponsor":"Jaeb Center for Health Research","startDate":"2023-04-20","conditions":"Cystic Fibrosis","enrollment":300},{"nctId":"NCT02919592","phase":"NA","title":"Memory Gel and Shape Combined Cohort","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mentor Worldwide, LLC","startDate":"2016-09-01","conditions":"Primary Breast Augmentation, Primary Breast Reconstruction, Revision Breast Augmentation","enrollment":3603},{"nctId":"NCT07470294","phase":"","title":"Effectiveness of Different Surgical Techniques for Curative Treatment of Pilonidal Sinus Disease in the Pediatric Population","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Angers","startDate":"2026-04-01","conditions":"Sacrococcygeal Pilonidal Sinus","enrollment":90},{"nctId":"NCT06181669","phase":"","title":"Pneumonia Direct Pilot","status":"COMPLETED","sponsor":"Duke University","startDate":"2024-04-12","conditions":"Pneumonia, Bacterial, Ventilator Associated Pneumonia","enrollment":173},{"nctId":"NCT07280065","phase":"PHASE3","title":"REVEAL Study - Diagnostic Testing for PTSD Using the Senseye Diagnostic Tool","status":"RECRUITING","sponsor":"Senseye, Inc.","startDate":"2026-02","conditions":"PTSD - Post Traumatic Stress Disorder","enrollment":1900},{"nctId":"NCT06908967","phase":"NA","title":"A Performance Study Comparing the EyeMirage (Test Device) to Standard of Care (Reference Device) in Patients 18 to 65 Years of Age Undergoing Standard Eye Examinations Such as Visual Acuity, Visual Field, Color Vision, and Self-Paced Saccade for Various Conditions","status":"COMPLETED","sponsor":"Neuroptek Corporation Inc.","startDate":"2025-06-13","conditions":"Visual Function","enrollment":160},{"nctId":"NCT03808675","phase":"NA","title":"Aerobic Exercise in Parkinson's Disease","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2019-07-01","conditions":"Parkinson's Disease","enrollment":57},{"nctId":"NCT04358107","phase":"","title":"Optimal Methods of Disease Progression and Survival Analysis in Children and Adults Patients With Adrenocortical Cancer (ACC)","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2020-04-20","conditions":"Adrenocortical Carcinoma","enrollment":1000},{"nctId":"NCT07456345","phase":"NA","title":"Evaluation of the Impact of Preoperative Pelvic Floor Exercise on Incontinence After Laser Enucleation of the Prostate: a Feasibility Study.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Centre hospitalier de l'Université de Montréal (CHUM)","startDate":"2024-04-29","conditions":"BPH (Benign Prostatic Hyperplasia), Incontinence, Urinary, HoLEP","enrollment":30},{"nctId":"NCT07143162","phase":"NA","title":"YOGA-FIT: Protocol for a Crossover Trial Investigating the Feasibility and Impact of Yoga for People With Stroke","status":"NOT_YET_RECRUITING","sponsor":"Nova Scotia Health Authority","startDate":"2026-04-01","conditions":"Stroke","enrollment":40},{"nctId":"NCT07068113","phase":"NA","title":"Effects of Turkish Traditional Dances on Postmenopausal Osteopenic Women","status":"COMPLETED","sponsor":"Ankara Etlik City Hospital","startDate":"2025-02-19","conditions":"Osteopenic Women","enrollment":81},{"nctId":"NCT06835751","phase":"NA","title":"Optimizing HIV Pre-exposure Prophylaxis (PrEP) Among Women Who Use Drugs in Tanzania","status":"ACTIVE_NOT_RECRUITING","sponsor":"Johns Hopkins Bloomberg School of Public Health","startDate":"2025-07-25","conditions":"HIV, Mental Health, Substance Use (Drugs, Alcohol)","enrollment":200},{"nctId":"NCT06878521","phase":"NA","title":"Strengthening Emotional Regulation: a Group Intervention With Adolescents","status":"COMPLETED","sponsor":"Lorena Wenger Amengual","startDate":"2024-07-12","conditions":"Emotional Regulation","enrollment":69}],"_emaApprovals":[{"date":"","name":"Various","status":"Authorised","regulator":"EMA"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"molecularData":{"oral":false,"chemblId":"CHEMBL2106384","moleculeType":"Protein","molecularWeight":"632.72"},"_patentsChecked":true,"_warningLetters":[{"date":"03/28/2023","subject":"11/07/2022\tTodos Medical Ltd aka Todos Medical USA Inc\tCenter for Food Safety and Applied Nutrition"},{"date":"03/27/2026","subject":"Feedback form"}],"crossReferences":{"chemblId":"CHEMBL2106384"},"formularyStatus":[],"_offLabelChecked":true,"developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Immunology"],"_revenueScrapedAt":"2026-03-31 09:33:25.982148+00","biosimilarFilings":[],"recentPublications":[],"_drugWebsiteChecked":true,"_healthCanadaChecked":true,"companionDiagnostics":[],"_genericFilersChecked":true,"structuredTrialResults":[{"hr":"","nctId":"NCT04193410","phase":"","pValue":"0.210","ciLower":"","ciUpper":"","endpoint":"BMI Z-score","enrollment":315}],"genericManufacturerList":[],"phase":"marketed","status":"active","companyName":"Pfizer","companyId":"pfizer","modality":"Small molecule","firstApprovalDate":"","enrichmentLevel":5,"visitCount":8,"regulatoryByCountry":[{"country_code":"EU","regulator":"EMA","status":"pending","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"GB","regulator":"MHRA","status":"approved","approval_date":null,"mah":"","brand_name_local":null,"application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"pricingByCountry":[{"country_code":"US","currency":"USD","price_amount":"80000.00","price_per":"year","price_type":"annual_list","annual_cost_usd":null,"reimbursement_status":null}],"trialStats":{"total":8,"withResults":1},"validation":{"fieldsValidated":2,"lastValidatedAt":"2026-04-20T08:28:31.942264+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}